A cross-border quality agreement is the operating companion to the purchase contract for an injection molding supplier. It should identify the approved part definition, who performs each quality activity, what evidence is exchanged, when approval is needed, and how a problem is contained. This is especially valuable when the buyer, tool shop, molder, laboratory, warehouse, and final assembly site are in different countries or time zones. It turns broad expectations such as “good quality” into controlled, part-specific instructions that procurement, engineering, and production can use. Supplier-quality management is a collaborative, life-cycle activity rather than a price-only purchasing exercise. [4]
For buyers in Europe, North America, and the Middle East, use the agreement to make requirements understandable across organizations, not to copy a generic template. It should be consistent with the commercial contract but should not silently set universal tolerances, sampling levels, delivery dates, tool life, prices, or certifications. Those depend on the product, applicable law, risk, validated method, and negotiated terms. FDA guidance for contract drug manufacturing is sector-specific, yet its general discipline is useful here: document the parties’ activities and clearly delineate responsibilities. [1]
A signed agreement is useful only when it names the released revision, the responsible decision-maker, the required evidence, and the disposition path for a real part number. Keep commercial remedies in the main contract and make the quality agreement the controlled operating rulebook.
01
1. Establish scope, documents, and decision rights before production
Start with a scope page that identifies every covered buyer entity, injection molding supplier site, subcontracted process, part number, tool number, and manufacturing location. State the agreement’s relationship to the purchase order, quality manual, NDA, packaging specification, and governing commercial terms. Define the working language, controlled document repository, revision convention, units, time zone for notices, and named contacts for quality, engineering, purchasing, logistics, and urgent escalation.
Attach or reference the released injection molding technical drawing, 3D model where authorized, material grade and approved alternates, color or masterbatch definition, cosmetic zones, labeling, packaging, functional-test method, and applicable regulatory or customer requirements. Identify CTQs or special characteristics by feature and datum rather than relying on color highlights in an email. ISO/IAF guidance on external providers stresses verifying that purchase requirements are correct before communication, include statutory and regulatory requirements, and are matched to a risk-based level of control. [2]
Set authority explicitly. The buyer may own design release and deviation approval; the molder may own routine process execution and internal control; either party may have to notify the other of a risk. Name who may accept a concession, approve a sample, stop shipment, release a tool modification, or close a corrective action. A quality agreement should not authorize an undocumented verbal change simply because a local team needs to keep the press running.
02
2. Define the acceptance baseline and the evidence each shipment needs
Acceptance should begin with the part definition, not a broad claim that all production will be “to drawing.” Specify which features, material attributes, appearance zones, functions, and packaging conditions are checked; who checks them; the approved method and equipment; record format; traceability link; and release criteria. For dimensional reports, require the drawing revision, datum alignment, measurement method, units, measurement-equipment status, sample identity, inspection date, and result. This makes injection molding inspection evidence interpretable by a remote buyer rather than merely presentable.
Agree a part-specific control plan or inspection plan. It can identify incoming resin verification where appropriate, first-off or start-up checks, in-process checks, final inspection, visual standards, functional testing, and retained records. State whether a certificate of conformity, lot report, dimensional report, material certificate, or photo record is required for a particular shipment. Do not prescribe a universal sample size: the plan should reflect part risk, process knowledge, measurement capability, customer requirements, and any applicable standard. IATF’s publicly available sub-tier guidance illustrates control plans, job setup verification, traceability, monitoring, and verification of externally provided products. [3]
Define lot and status identification in terms that work at the receiving dock. A record might link finished-goods lot, resin lot, colorant lot when relevant, cavity or machine identification where practical, production date or shift, inspection record, packaging label, and shipment documentation. Agree the retention period, location, access method, and any data-protection limits. Traceability should be proportionate and feasible; an agreement should not imply that every product needs the same level of genealogy.
03
3. Control qualification and change instead of treating approved samples as permanent approval
The agreement should state what evidence is needed before initial production release and after a material change, tool move, major repair, new cavity, different molding site, or other defined change. Depending on the program, this may include a DFM review, trial record, first-article dimensions, material evidence, appearance assessment, functional results, capability study, or a customer-specific submission. Describe the required acceptance criteria and decision owner. Injection molding process validation should be proportionate to the application and agreed before the run; it is not a universal promise that a process will remain unchanged under every resin lot, machine, or environment.
Build a written change-control matrix. List changes that require advance notice, changes requiring written buyer approval before implementation, and emergency containment actions that can be taken immediately with rapid notification. Examples to evaluate include resin grade or source, colorant, regrind policy, tool steel or cavity repair, gate or vent change, machine or site move, critical fixture, inspection method, packaging, and subcontracted secondary operation. IATF’s supplier guidance specifically includes change control and notification, while noting that temporary process-control changes require management. [3]
Set a reviewable workflow: change request, risk assessment, proposed evidence, approval or rejection, implementation date, revised documents, first-lot identification, and closure confirmation. Require the supplier to preserve the prior approved baseline until approval is recorded, except where safety or containment requires otherwise. If the buyer accepts a temporary deviation, define its quantity, lot, expiry, labeling, and follow-up.
04
4. Make nonconformance, corrective action, audits, and continuity executable
Define nonconformance in practical terms: suspected or confirmed out-of-specification product, wrong material or labeling, failed test, damaged packaging, missed record, or unapproved change. The supplier should segregate and identify suspect material, stop or contain affected flow as appropriate, preserve evidence, notify the named buyer contact within the agreed trigger and time frame, and request disposition. The buyer should define who can authorize use-as-is, rework, scrap, return, or additional inspection. IATF guidance similarly separates control of nonconforming, suspect, reworked, and repaired product, customer notification, and authorization for concession. [3]
For corrective action, agree what a useful response contains: a clear problem statement, affected part and lots, immediate containment, verified root-cause method, corrective and preventive actions, owners, target dates, and effectiveness review. Avoid treating a generic 8D form as proof of root cause. Ask for objective evidence that the control was implemented and that the recurring mechanism was challenged. The agreement can require escalation for repeat issues, field impact, safety concern, or shipment risk, without predicting a fixed resolution time.
Address supplier monitoring and access in a workable way. The buyer may request periodic KPI review, remote document review, or an on-site audit with reasonable notice, subject to safety, confidentiality, export-control, and local-law constraints. Discuss continuity: critical sub-suppliers, approved backup sources, emergency contacts, data backup, tool storage, and communication during disruption. ISO/IAF guidance notes that approved-supplier lists alone may be insufficient and that performance monitoring and supply-chain controls matter. [2]
Practical takeaway
Before you move
to the next review.
- Identify covered parts, revisions, tools, sites, subcontractors, document source, contacts, and escalation route.
- Reference released drawings, material, appearance, CTQs, test, packaging, and applicable requirements.
- Define inspection, lot identity, records, retention, shipment evidence, and acceptance or concession authority.
- Set release and change evidence, notification triggers, approval gates, first-lot identification, deviation limits, and updates.
- Set nonconformance, containment, corrective-action, audit, performance-review, and continuity responsibilities.
FAQ
Common questions
Is a supplier quality agreement the same as the purchase contract?
Not exactly. The purchase contract governs commercial scope, payment, liability, ownership, and remedies. The quality agreement sets operating rules: responsibilities, acceptance evidence, records, approvals, and escalation. It should defer conflicts to the governing contract.
Which changes should an injection molding supplier notify before implementing?
Specify this by program. Typical triggers are resin, colorant, tool, machine or site, inspection, packaging, or subcontractor changes. State when advance notice alone is enough and when written approval and validation evidence are required.
Must every cross-border molding program use PPAP?
No. Use PPAP when a customer or sector requires it; otherwise name the release evidence needed, such as first-article dimensions, material documents, functional results, and a control plan.
How should a buyer handle a suspected nonconforming shipment?
Require lot identification, hold or segregation, prompt notice, preserved evidence, and an agreed disposition. Containment should reflect part risk, location, contract terms, and legal obligations.
References
Source material
- [1] U.S. Food and Drug Administration, Contract Manufacturing Arrangements for Drugs: Quality Agreements Guidance for Industry
- [2] ISO 9001 Auditing Practices Group, External Providers Guidance
- [3] International Automotive Task Force, Minimum Automotive Quality Management System Requirements for Sub-Tier Suppliers
- [4] American Society for Quality, Supplier Quality
This guide is general information for early procurement and engineering discussion. It does not replace product-specific DFM, qualification, validation, regulatory assessment or legal advice.